TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
NTLA

Intellia Therapeutics Inc

Healthcare · Biotechnology

12.30$ -2.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Intellia Therapeutics Inc (NTLA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 857 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NTLA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,243 1,301 1,260 1,192 1,173 1,191 986 899 925 842 759 857
893 998 884 757 711 640 551 496 582 528 466 528
168 227 172 131 120 189 127 156 193 155 135 106
855 912 791 691 658 602 504 460 511 450 376 438
6.5 36 36 12 8.9 8.5 11 11 11 9.5 9.1 7.3
-138 – 0.0 – – – – – – – – –
206 251 223 220 211 319 206 184 177 171 138 129
92 115 98 105 106 111 113 95 94 104 76 79
17 19 19 19 19 20 39 27 27 26 19 23
3.6 7.5 14 19 13 15 12 9.8 13 20 19 12
1,037 1,050 1,036 971 963 872 780 715 748 671 621 728
-1,526 -1,658 -1,766 -1,913 -2,049 -2,177 -2,292 -2,393 -2,494 -2,590 -2,686 -2,793
89 90 96 97 101 102 104 104 110 108 118 133

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?